Literature DB >> 2291568

Development of a high-titer retrovirus producer cell line and strategies for retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells.

D M Bodine1, K T McDonagh, N E Seidel, A W Nienhuis.   

Abstract

Retroviral-mediated gene transfer into pluripotent hematopoietic stem cells has been difficult to achieve in large animal models. We have compared several infection protocols in a murine model system and concluded that bone marrow can be maintained and infected in vitro for 2-6 days. We have also developed an amphotropic producer clone that generates greater than 10(10) recombinant retroviral particles (CFU) per milliliter of culture medium. Autologous rhesus monkey bone marrow cells were co-cultured with either high- (2 x 10(10) CFU/ml) or low- (5 x 10(6) CFU/ml) titer producer clones for 4-6 days and reinfused into sublethally irradiated animals. The proviral genome was detected in blood and bone marrow cells from all three animals reconstituted with cells co-cultured with the high-titer producer cells. In contrast, three animals reconstituted with bone marrow co-cultured with the low-titer producer clone exhibited no evidence of gene transfer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291568     DOI: 10.1111/j.1749-6632.1990.tb24329.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Gene therapy vectors as drug delivery systems.

Authors:  S A Afione; C K Conrad; T R Flotte
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 2.  Prospects for virus-based gene therapy for cystic fibrosis.

Authors:  T R Flotte
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.